Registry-based study reveals higher odds of Staphylococcus aureus infection among systemic glucocorticoid users, highlighting potential risks of immunosuppressive therapy.
Current users of systemic glucocorticoids experienced 2.5 times higher odds of infection with Staphylococcus aureus bacteria than non-users, a Danish study published in Mayo Clinic Proceedings has found.1 Glucocorticoids are potent immunosuppressive drugs used widely in treating acute and chronic conditions across almost all clinical specialties. The researchers used medical registries in northern Denmark to analyse …
No takes yet. Share an insight, caveat, or question.
Jacqui Wise (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: